Discovery of novel 1,3,5‐triazine as adenosine A 2A receptor antagonist for benefit in Parkinson's disease-Reference-Cited by-同舟云学术

Discovery of novel 1,3,5‐triazine as adenosine A 2A receptor antagonist for benefit in Parkinson's disease

Published:2020-11-06 Issue:3 Volume:35 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Masih Anup¹,Agnihotri Amol K.¹,Srivastava Jitendra K.¹,Pandey Nidhi²,Bhat Hans R.³^ORCID,Singh Udaya P.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Drug Design & Discovery Laboratory Sam Higginbottom University of Agriculture, Technology & Sciences Allahabad Uttar Pradesh India

2. Department of Medicine and Health Sciences University Rovira i Virgili Tarragona Spain

3. Department of Pharmaceutical Sciences Dibrugarh University Dibrugarh Assam India

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22659

Reference50 articles.

1. Parkinson disease

2. Non-motor features of Parkinson disease

3. Ageing, neurodegeneration and brain rejuvenation

4. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

5. Parkinson disease: from pathology to molecular disease mechanisms

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid PABA‐glutamic acid conjugated 1,3,5‐triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme;Chemical Biology & Drug Design;2023-10-02

2. Antitumor Activity of s-Triazine Derivatives: A Systematic Review;Molecules;2023-05-23

3. Design and development of novel N ‐(4‐aminobenzoyl)‐ l ‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf ‐DHFR inhibitor: An in‐silico and in‐vitro study;Journal of Biochemical and Molecular Toxicology;2022-12-21

4. Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA1 and hA3 Adenosine Receptor;Molecules;2022-06-22

5. Adenosine receptor antagonists: Recent advances and therapeutic perspective;European Journal of Medicinal Chemistry;2022-01